Translational Development Acquisition Corp.

TDAC Nasdaq CIK: 0001926599

Company Information

Industry Blank Checks
SIC Code 6770
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
Business Address 52 E 83RD ST., NEW YORK, NY, 10028
Mailing Address 52 E 83RD ST., NEW YORK, NY, 10028
Phone (413) 204-2769
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment October 10, 2025 View on SEC
10-Q Quarterly financial report August 14, 2025 View on SEC
8-K Current report of material events August 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment July 31, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment July 11, 2025 View on SEC
10-Q Quarterly financial report May 15, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment May 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment May 14, 2025 View on SEC

Annual Reports

10-K March 30, 2026
  • Successfully raised $172.5 million in a December 2024 IPO.
  • Capital is held in a secure trust account for future biotech/healthcare acquisitions.
View Analysis

Related Companies

Companies in the same industry (SIC: 6770)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.